prediabetes and glp 1 Glucagon-like peptide-1 receptor: mechanisms advances in therapy Episode 481: Prediabetes & Diabetes

Limited case reports of accidental first-trimester exposure did not report severe adverse outcomes, but extended use carries greater theoretical risk

Back DiMarchi, R Efendic, S (1997) 'Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity', US Patent US6191102B1.Back Drucker, DJ, Habener, JF, Holst, JJ (1 Dec 2017) 'Discovery, characterization, and clinical development of the glucagon-like peptides', Journal of Clinical Investigation , 127/12, 4217-27

B., Berntzen, G., Michaelsen, T

Namun, antioksidan ini juga dapat menjadikan sel kanker lebih kebal melawan pengobatan kemoterapi

Glucose metabolism modulation Studies suggest it may inhibit gluconeogenesis (glucose production in the liver) and enhance glycolysis (glucose breakdown), thereby potentially reducing blood glucose levels

High or frequent dosing is the main concern, and people with kidney, liver or other conditions are most at risk